Polymyxin E2 Methanesulfonate for Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polymyxin E2 Methanesulfonate for Injection, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria [Phase 2]